3 gene mutations appear to be invasion mechanisms
Researchers at Case Western Reserve University and Cleveland Clinic Lerner Research Institute have discovered recent genetic mutations in a parasite that causes over 100 million cases of malaria annually—changes that may render tens of millions of Africans who had been considered resistant, susceptible to infection.
Peter A. Zimmerman, professor of international health, biology and genetics at the Case Western Reserve School of Medicine, and David Serre, a scientific staff member of the Genomic Medicine Institute at Lerner and assistant professor of genomics at Case Western Reserve, report their findings at the American Society of Tropical Medicine and Hygiene annual meeting today (11/15).
They and fellow researchers describe the changes in the Plasmodium vivax genome in papers scheduled to be published in the journal PLoS Neglected Tropical Disease on Nov. 21 and Dec. 5.
To learn the functions of the mutations, and whether the parasite is evolving around a natural defense, Zimmerman and Serre have received a $3.5 million grant from the National Institute of Allergy and Infectious Disease at the National Institutes of Health. They will begin their field study in early 2014.
“We’ve found a duplication of a gene known to enable the parasite to infect red blood cells and two possible additional components to a more complex red cell invasion mechanism,” Zimmerman said.
Researchers have long thought that P. vivax infects a person one way: a protein on the parasite, called the Duffy binding protein, latches onto a Duffy receptor on the surface of the person’s red blood cell and works itself through the membrane. People who lack the receptor are called Duffy negative and are resistant to infection.
But, during the last decade, reports of cases of Duffy negative patients with P. vivax infections have been on the rise in several parts of the world.
P. vivax has been called benign malaria because it is less lethal than malaria caused by Plasmodium falciparum. But unlike its cousin, P. vivax can hide from treatment in a host’s liver and repeatedly emerge to cause relapses of debilitating headaches, nausea and fever. This chronic malaria often triggers a cycle of poverty for sufferers left unable to work for long periods. By weakening the immune system, the disease contributes to death.
The Malaria Atlas Project estimates 2.5 billion people worldwide are at risk for P. vivax malaria.
P. vivax does not grow well in the laboratory, so to try to understand how the parasite lives and operates, the researchers gathered samples from malaria patients and focused on its genome.
They found a duplication of the Duffy binding protein in half of 189 P. vivax infection samples taken in Madagascar. Other researchers’ prior efforts to sequence the P. vivax genome missed the duplication but all indications are it’s a recent change, Serre said.
“The way we date duplications is to compare differences between the two parts: the more different they are, the older they are,” he explained. “They accumulate mutations. The two parts of this duplication have, among 8,000 base pairs, only one difference.”
Often a second copy of a gene enables an organism to outmaneuver a defense, Serre continued. “Instead of making a supergene, a duplication is simpler for nature.”
The researchers suspect the mutation is spreading from Madagascar through travelers. They found the duplication in less than 10 percent of samples from Cambodia and Sudan.
The new components found on the P. vivax genome are two proteins that closely resemble binding proteins used by related malaria parasites to enter immature and mature red blood cells. Both were present in samples from Cambodia, Brazil, Mauritania and North Korea.
The new proteins were absent in a 2008 sequencing of P. vivax, which is used as a reference genome, suggesting the developments are recent.
“Binding proteins and receptors are locks and keys,” Zimmerman said. “If the parasite has one key and there’s one lock, you may be able to block that. But if it has more keys and there are more locks, there are multiple ways in.”
The researchers say the duplication may be a cause of the growing infections among Duffy negative people, but it’s too early to tell.
Zimmerman, Serre and colleagues aim to find the answer with the newly-funded research project. They’ll begin by studying blood samples taken from 1,500 patients at each of two locations in Madagascar.
They and colleagues have great concern that a loss of resistance to P. vivax infection will now enable the parasite to travel the 250 miles across the Mozambique Channel to Africa. There, falciparum malaria is wrecking havoc on a population that has for the most part lived P. vivax-free. In some regions of the continent, 100 percent of the population is Duffy negative.
Go deeper with Bing News on:
- FDA allows malaria drugs from dodgy Indian manufacturer to access US marketon March 24, 2020 at 9:09 am
Panic-buying in Africa is bizarre because, although Africa is home to about 90 percent of the world’s malaria cases, these are overwhelmingly falciparum malaria and not vivax malaria. Falciparum ...
- Adequate Primaquine for Vivax Malariaon March 17, 2020 at 5:00 pm
Background: Treatment of vivax malaria with primaquine prevents the relapse of infection from residual liver stages of the parasite. Inadequate dosage is related to a higher relapse risk.
- Why Shakespeare would have been obsessed with coronaviruson March 15, 2020 at 4:00 am
Ague was a general term for fever but was usually associated with the fevers brought on by malaria. “Quotidian tertian” is a specific reference to regularly occurring fevers and the periods between ...
- Local Transmission of Plasmodium vivax Malaria - Virginia, 2002on March 12, 2020 at 5:00 pm
[1,2,3] This report describes the investigation of two cases of Plasmodium vivax malaria that occurred in northern Virginia in August 2002, and underscores the need for clinicians to consider the ...
- A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaon March 6, 2020 at 4:00 pm
Today, 3 billion people are at risk of malaria in 97 countries, leading to 200 million cases annually caused primarily by Plasmodium falciparum and Plasmodium vivax. Pregnant women and nonimmune naïve ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Contract for the Web
- Amazon slams Pentagon's approach to fix messy $10 billion JEDI cloud contract, new court docs showon March 24, 2020 at 2:44 pm
Amazon Web Services argued the Pentagon's proposed review of the $10 billion JEDI cloud contract award would only succeed at giving Microsoft a "do-over," according to filings mad ...
- You won't contract coronavirus from Phoenix-area tap water. Here's whyon March 24, 2020 at 1:32 pm
As the novel coronavirus spreads and bottled water has flown off store shelves, officials say tap water is safe to drink.
- JEDI Contract to Have Only One Masteron March 24, 2020 at 12:09 pm
Rumors had circulated that the lucrative Joint Enterprise Defense Infrastructure (JEDI) contract might be jointly awarded to Microsoft Azure and Amazon Web Services. However, a Pentagon spokesman said ...
- Giants Rumors: Darrelle Revis' Cousin Dravon Askew-Henry Agrees to Contracton March 24, 2020 at 11:16 am
Per NFL Network's Ian Rapoport, the Giants are giving Askew-Henry a two-year contract and will let him compete for time as the nickel cornerback. This article will be updated to provide more ...
- AWS "concerned" DoD's JEDI rethink "fails the tests of rationality and fairness," won't go far enoughon March 24, 2020 at 10:28 am
With the Department of Defense telling a court that it wishes to reconsider awarding Microsoft a major cloud contract, one would think that litigator and competitor AWS would be in a good mood. But ...